乳腺癌放疗深吸气屏气首日评估的临床研究
该回顾性研究分析1920例术后乳腺癌放疗患者,评估深吸气屏气(DIBH)可行性,发现4%因转换至自由呼吸而重新计划。年龄≥63岁、肺部合并症、较高Charlson合并症指数及DIBH与FB间几何表面距离<1 cm是DIBH失败的显著预测因素。
要点
- 年龄≥63岁与DIBH失败再计划率显著相关(p=0.001)。
- 肺部合并症、较高CCI及几何位移<1 cm是DIBH失败的显著预测因素。
- KPS、BMI和吸烟状态与再计划无显著关联。
核心结论
- 年龄、肺部合并症、整体合并症负担及几何位移不足是乳腺癌放疗中DIBH失败的显著预测因素。
主要发现
- 全队列1920例中,78例(4%)因从DIBH转换为自由呼吸而重新计划。
- 年龄增加(切点63岁)与更高的再计划率显著相关(p=0.001)。
- 2023年亚组分析(n=470)中,肺部合并症(p=0.008)、较高CCI(p=0.044)及DIBH与FB CT扫描间几何表面距离低于1 cm(p=0.0001)是再计划的显著预测因素。
- KPS、BMI和吸烟状态与再计划无显著关联。
关键数值与推荐
- 年龄切点63岁与再计划率显著相关(p=0.001)。
- 肺部合并症p=0.008、较高CCI p=0.044、几何表面距离<1 cm p=0.0001为显著预测因素。
临床怎么用
- 可利用年龄、肺部合并症、CCI及几何位移等易得临床参数优化患者选择算法。
- 风险分层方法可减少不必要的影像检查、降低计划负担并改善资源分配,同时为合适候选者维持最佳心脏保护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deep inspiration breath-hold (DIBH) is a radiotherapy standard technique for cardiac-sparing in breast cancer, particularly for left-sided tumors. However, not all patients can successfully complete DIBH RT in clinical routine, necessitating conversion to free breathing (FB) techniques and replanning. This study aimed to identify clinical factors predictive of DIBH feasibility to optimize patient selection and resource utilization. METHODS: This retrospective study analyzed all patients (n = 1920) who underwent curative postoperative breast cancer radiotherapy at our institution between May 2020 and December 2024. All patients underwent initial DIBH feasibility assessment and were evaluated for completion of radiotherapy with DIBH or conversion to FB technique. A detailed subanalysis was performed for all patients treated in 2023 (n = 470). Patient-related factors including age, body mass index (BMI), Karnofsky Performance Status (KPS), Charlson Comorbidity Index (CCI), pulmonary comorbidities, smoking status, and geometric surface distance between DIBH and FB planning scans were collected for the subanalysis. RESULTS: Across the entire cohort (years 2020-2024) of 1,920 patients, 78 replannings (4%) occurred due to conversion from DIBH to free breathing. Increasing age (cut-off of 63 years) was significantly associated with higher replanning rates (p = 0.001). In the 2023 subanalysis (n = 470), pulmonary comorbidities (p = 0.008), higher CCI (p = 0.044), and a geometric surface distance of below 1 cm between DIBH and FB CT scans (p = 0.0001) were significant predictors of replanning. The Karnofsky Performance Score, BMI, and smoking status showed no significant association with replanning. CONCLUSIONS: Age, pulmonary comorbidities, overall comorbidity burden, and insufficient geometric displacement are significant predictors of DIBH failure in breast cancer radiotherapy. These readily available clinical parameters can optimize patient selection algorithms and inform decisions regarding dual CT simulation workflows. A risk-stratified approach incorporating these factors may reduce unnecessary imaging, decrease planning burden, and improve resource allocation while maintaining optimal cardiac protection for appropriate candidates. CLINICAL TRIAL NUMBER: The study was registered in the German Clinical Trials Register (DRKS; registration number: DRKS00038550) on 22 December 2025 ( https://www.drks.de/ ).
引用
- Cepni B, Batista V, Hoeltgen L, et al. Clinical evaluation using first-day assessment of patient suitability for successful performance of deep inspiration breath-hold for breast cancer radiotherapy. Radiat Oncol. 2026. PMID: 42687171. doi:10.1186/s13014-026-02919-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。